Senseonics to take over Eversense 365 commercialization from Ascensia
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/5/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
Senseonics Signs Memorandum of Understanding with Ascensia Diabetes Care to Take Over Commercialization and Distribution of Eversense 365
September 3, 2025 5:17 PM EDTCGM commercial operations to transition from Ascensia Diabetes Care to Senseonics
Brian Hansen to be appointed Chief Commercial Officer
Non-dilutive debt facility expanded up to $100 million with Hercules Capital to fund commercial organization
Conference Call scheduled for September 4, 2025 at 8:00 A.M. Eastern Time
GERMANTOWN, Md., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes,... More
